News
Short summaries of MS news, each pointing back to the organisation that published it. Items appear here only after an editor has approved the draft, so this page moves slowly on purpose.
43 of 43 stories shown, newest first
Research · International
Remibrutinib: phase III MS results announced
Novartis reports that remibrutinib reduced relapse rates compared with teriflunomide in two phase III studies of relapsing MS. These are initial manufacturer results, with fuller data planned for a scientific meeting. The company plans applications for MS regulatory approval.
Novartis · 2026-09-01 · Manufacturer-reported phase III topline results
diagnosis
Earlier diagnosis requires more than new criteria
An open-access paper on how the updated McDonald criteria can support earlier MS diagnosis, and what health systems need in place to act on it.
MS International Federation · 2026-08-26
Research · United Kingdom
Virtual reality rehabilitation: early feasibility findings
A study involving 19 people with MS tested virtual reality games for arm and hand rehabilitation. Participants generally found the sessions enjoyable and workable. The small study assessed feasibility and safety; larger studies are needed to establish benefits for arm and hand function.
MS Society UK · 2026-08-21 · Small feasibility study
Access to care · England
Fampridine access: NHS England recommendation reported
MS Trust reports that NHS England has recommended fampridine for people with MS who have walking difficulties. The announcement concerns access in England. Fampridine targets walking symptoms, and eligibility and suitability still require assessment by the treating team.
MS Trust · 2026-07-20 · Charity report of NHS access announcement
Access to care · England
A proposed framework for neurological care in England
MS Trust describes a proposed national framework intended to improve coordination of neurological care in England. Priorities include multidisciplinary teams, earlier support and more community care. This is a call for service reform, rather than confirmation that the proposed framework has been implemented.
MS Trust · 2026-06-15 · Policy proposal
Research · England
Heart and stroke risk tools may need MS-specific validation
Researchers examining English health records found that commonly used cardiovascular risk calculators often underestimated risk in people with MS. The findings support further work on tools tailored to MS. They do not provide an individual risk estimate or establish a new clinical calculator.
MS Society UK · 2026-06-03 · Observational validation study
Research · United Kingdom
REFINE-MS will study longer ocrelizumab treatment intervals
UCL has launched REFINE-MS to investigate whether some people with relapsing-remitting MS can receive ocrelizumab less often while maintaining disease control. The study compares treatment intervals. It has not established that patients should change their existing treatment schedules.
UCL Innovative Clinical Trials Unit · 2026-06-01 · Trial launch
Research
New research uncovers blood biomarkers linked to MS risk
Researchers identified blood proteins that may act as early signs of MS years before symptoms appear.
National MS Society · 2026-06-01
Community · International
MS organisations make prevention a shared research priority
MS organisations from several countries have signed the Nice Declaration, committing to make prevention a shared research priority. The initiative promotes international collaboration and involvement of people affected by MS. It announces a research commitment, not an established method of preventing MS.
MS Society UK · 2026-05-30 · Joint research declaration
Research · United Kingdom
Myelin repair and inflammation: findings from a rat study
Researchers studying rats found that repair of damaged myelin was linked with resolution of inflammation in connected brain regions. Blocking repair left inflammation unresolved. The findings help explain disease mechanisms, but do not demonstrate that a new treatment works in people with MS.
MS Society UK · 2026-05-25 · Preclinical animal study
Research
Introducing MS Trust's research grants portal
MS Trust has launched a new grants portal to fund clinician-led, practice-based research that improves MS care, reduces inequalities, and delivers real-world impact for people living with MS.
MS Trust news and stories · 2026-05-22
Treatments · European Union
Cenrifki: April recommendation followed by June EU authorisation
EMA’s committee recommended Cenrifki, containing tolebrutinib, for adults with non-relapsing secondary progressive MS. This April report describes a recommendation; EMA’s later medicine record confirms EU authorisation on 19 June 2026. That current record includes liver-monitoring requirements.
European Medicines Agency · 2026-04-24 · Regulatory recommendation with subsequent authorisation update
Research · United Kingdom
Refuel-MS fatigue trial reaches its recruitment target
The Refuel-MS trial has reached its recruitment target of 380 participants. Researchers are evaluating an app supported by healthcare professionals to help manage fatigue. Initial results are expected in 2027, so this milestone does not yet show whether the intervention is effective.
MS Society UK · 2026-03-30 · Recruitment milestone; results pending
Research · England
English health records show changing MS prevalence and survival
An analysis of English health records found rising recorded MS prevalence and improving survival over time, alongside inequalities linked with deprivation. Researchers suggest better diagnosis and longer survival contribute to the trend. These population findings cannot establish an individual person’s prognosis.
UCL · 2026-03-23 · Observational health-records study
Research
What's next? The 2026 ACTRIMS Forum looks to the future of MS research
Meeting highlights from the 11th annual ACTRIMS Forum, held 4-7 February 2026, summarised by the National MS Society.
National MS Society · 2026-02-18
Research
Two new studies build the case for EBV's role in triggering MS
Two reports add to the evidence on how Epstein-Barr virus may be involved in triggering MS.
National MS Society · 2026-01-23
Research · United Kingdom
AI study identifies biological patterns in MS trial data
In an analysis of MRI scans and blood markers from 634 trial participants, UCL researchers identified two biological patterns linked to MS activity. The research could inform future stratification; it does not establish new routine diagnostic categories for people with MS.
UCL · 2026-01-05 · Exploratory clinical-data analysis
Research
What the King’s Speech means for people with MS
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
NHS considering funding fampridine in England
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
Funding for two MS research centres renewed
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
MS Awareness Week: Survey reveals the impact of assumptions
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
What will the Employment Rights Bill mean for people with MS?
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
28 April 2026 Why neurorehabilitation must become a right, not a luxury Thriving Not Surviving - The case for a right to neurorehabilitation
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Trust news and stories
Research
Our research leadership
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Trust news and stories
Research
Latest research news
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
New study highlights impact of inequality in MS
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
11 May 2026 On International Nurses Day - thank you International Nurses Day: Thank you to MS Nurses who are supporting better MS care.
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Trust news and stories
Research
Timms Review interim report: PIP no longer fit for purpose
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
APPG for MS hosts a joint meeting with APPG on Parkinson’s in parliament
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
24 August 2026 Maria's story Maria shares how MS relapses can cause walking difficulties and come as a major disruption to daily life. Highlighting how she has learnt to recognise early warning signs, identify personal triggers such as
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Trust news and stories
Research
PIP review launches consultation
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
6 May 2026 Fatigue, more than just being tired Casiana shares her experience of living with fatigue, offering ways to recognise and manage it.
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Trust news and stories
Research
14 May 2026 Learning to listen to fatigue Kezia shares her experience of learning to recognise and respond to fatigue, managing it realistically by prioritising self‑care and seeking support when needed.
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Trust news and stories
Research
The future of biosimilar treatments for MS
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
Fampridine recommended for use in England
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
New ABN pregnancy and MS guidelines
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
How an MS diagnosis led to £1 million raised for research
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
Explore our research
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
The history of MS research
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
Take part in MS research
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
Proud to be marching in Prides in London and Edinburgh!
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news
Research
our sign up form here
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Trust news and stories
Research
Neurological conditions: the case for a modern service framework
Automatically collected candidate. An editor must write the summary and approve it before publication.
MS Society UK research news